☆ 4.7 Letter

Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab

PROTEIN & CELL (2018)

Get Full Text
Add to Collection

Journal

PROTEIN & CELL
Volume 9, Issue 1, Pages 135-139

Publisher

HIGHER EDUCATION PRESS
DOI: 10.1007/s13238-017-0412-8

Keywords

-

Categories

Cell Biology

Funding

  1. National Natural Science Foundation of China [31390432, 31500722]
  2. National Basic Research Program (973 Program) [2013CB531502]
  3. NSFC Innovative Research Group [81621091]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.